Circulating Tumor Cells in Solid Tumors
NCT03161821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206
Last updated 2022-09-28
Summary
The purpose of this study is to identify circulating tumor cells in patients with solid tumors. Quantify and characterize these cells, collect patient information in regards to the patient's cancer. Develop a database and a sample repository where future analysis could be done.
Conditions
- Solid Tumor, Adult
Interventions
- OTHER
-
Observational
Sponsors & Collaborators
-
UNC Lineberger Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Lisa A Carey, MD · University of North Carolina
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-09
- Primary Completion
- 2021-02-16
- Completion
- 2021-02-16
Countries
- United States
Study Locations
More Related Trials
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
NCT01137643 ·Status: RECRUITING
-
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
NCT00904514 ·Status: TERMINATED
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001163 ·Status: ACTIVE_NOT_RECRUITING
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Collection of Circulating Tumor Cells From the Peripheral Blood of Metastatic Breast Cancer Patients
NCT02904135 ·Status: COMPLETED
-
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
NCT02245100 ·Status: COMPLETED
-
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
NCT00039676 ·Status: ACTIVE_NOT_RECRUITING
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Biology Studies of Hematologic Cancers
NCT00923442 ·Status: ENROLLING_BY_INVITATION
-
Collection of Blood Specimens for Circulating Tumor Cell Analysis
NCT01943500 ·Status: COMPLETED
-
Analysis of Circulating Tumor Markers in Blood
NCT04025541 ·Status: RECRUITING ·Phase: NA
-
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
NCT03189108 ·Status: TERMINATED
-
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
NCT00043615 ·Status: COMPLETED
-
Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma
NCT01173445 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
NCT01433224 ·Status: COMPLETED
-
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
NCT00900471 ·Status: RECRUITING
-
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
NCT05096923 ·Status: RECRUITING
-
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
NCT00898781 ·Status: TERMINATED
-
A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer
NCT05574738 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
NCT00610415 ·Status: COMPLETED
-
Establishment and Application of 3-Dimensional (3-D) Cell Culture Model of Clinical Circulating Tumor Cells (CTCs)
NCT05623748 ·Status: COMPLETED
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
NCT01457196 ·Status: COMPLETED ·Phase: NA
-
Screening Study for Participants With Malignant Tumors
NCT05419375 ·Status: COMPLETED ·Phase: PHASE2